Wednesday, January 29, 2014

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over...

Background: A 6-month phase 2 study of fingolimod demonstrated efficacy and safety in Japa http://t.co/dxs8fsZ17j

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/dxs8fsZ17j
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)